XML 59 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Employee Compensation (Tables)
 12 Months Ended
Oct. 01, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Components of Share-Based Compensation Expense The components of share-based compensation expense, included within “Selling, general, and administrative expenses” in our consolidated statements of earnings, in each fiscal year are as follows (in thousands):
202320222021
Nonvested restricted stock units$7,598 $4,544 $2,969 
Stock options4 19 25 
Performance share awards3,195 1,835 830 
Nonvested restricted stock awards166 434 — 
Non-management directors’ deferred compensation242 290 224 
Total share-based compensation expense$11,205 $7,122 $4,048 
Summary of RSU Activity
The following is a summary of RSU activity for fiscal 2023:
SharesWeighted-
Average Grant
Date Fair
Value
RSUs outstanding at October 2, 2022236,606 $75.98 
Granted186,938 $68.56 
Released(55,919)$81.97 
Forfeited(39,089)$74.01 
RSUs outstanding at October 1, 2023328,536 $70.97 
SharesWeighted-
Average Grant
Date Fair
Value
Restricted stock awards outstanding at October 2, 20224,670 $82.33 
Issued(4,670)$82.33 
Restricted stock awards outstanding at October 1, 2023— $— 
Summary of Stock Option Activity
The following is a summary of stock option activity for fiscal 2023:
SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term (Years)		Aggregate
Intrinsic
Value
(in thousands)
Options outstanding at October 2, 202232,450 $92.80 
Exercised(3,500)$75.23 
Options outstanding at October 1, 202328,950 $94.92 1.11$— 
Options exercisable at October 1, 202328,950 $94.92 1.11$— 
Summary of PSU Activity
The following is a summary of performance share award activity for fiscal 2023:
SharesWeighted-
Average Grant
Date Fair
Value
Performance share awards outstanding at October 2, 202265,382 $79.14 
Granted56,466 $65.74 
Issued(1,126)$70.56 
Forfeited(13,548)$77.54 
Performance share awards outstanding at October 1, 2023107,174 $72.51 
Summary of Stock Equivalent Activity
The following is a summary of the stock equivalent activity for fiscal 2023:
Stock
Equivalents		Weighted-
Average Grant
Date Fair
Value
Stock equivalents outstanding at October 2, 2022116,274 $45.28 
Deferred directors’ compensation3,072 $81.38 
Dividend equivalents3,635 $78.51 
Stock equivalents outstanding at October 1, 2023122,981 $47.16